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Auditory neuropathy in a patient exposed to xylene: case
report
THJD RAPER, D-E BAMIOU*
Abstract
Objective: To report the case of an adult patient who developed auditory complaints following xylene exposure,
and to review the literature on the effects of solvent exposure on hearing.
Case report: The patient presented with a gradual deterioration in his ability to hear in difﬁcult acoustic
environments and also to hear complex sounds such as music, over a 40-year period. His symptoms began
following exposure to the solvent xylene, and in the absence of any other risk factor. Our audiological
investigations revealed normal otoacoustic emissions with absent auditory brainstem responses and absent
acoustic reﬂexes in both ears, consistent with a diagnosis of bilateral auditory neuropathy. Central test results
were also abnormal, indicating possible involvement of the central auditory pathway.
Conclusions: To our knowledge, this is the ﬁrst report of retrocochlear hearing loss following xylene exposure.
The test results may provide some insight into the effect of xylene as an isolated agent on the human auditory
pathway.
Key words: Auditory Neuropathy; Hearing; Xylene; Solvent Exposure
Introduction
Organic solvents are common in industrial environments
and are used in large quantities across the world. Some of
the more common solvents include xylene, toluene and
styrene and can be found in household items such as
paints, pharmaceuticals, adhesives, pesticides and house-
hold cleaners. However, research suggests that long term
or acute exposure to solvents can have noxious, neurotoxic
and ototoxic effects.
1
Humans with long term oracute exposure to solvents have
demonstrated hearing losses greater than would be expected
for their age
2–6 and, when working in industrial environ-
ments using solvents, greater than would be expected for
noise exposure alone.
3–5,7 There is also evidence that
solvent exposure may result in retrocochlear rather than per-
ipheral cochlear lesions in humans. For example, impaired
speech recognition scores consistent with a retrocochlear
pattern and/or abnormal cortical responses and/or abnormal
reﬂex decay have been reported in populations working with
toluene,
5 jet fuels,
8 styrene
9 and mixtures of solvents.
8,10–12
It is now documented that solvents should be considered
as individual substances with different speciﬁc toxicities,
12
and that solvents may act on transmitters speciﬁc for
certain neural structures and pathways.
10 For example, sig-
niﬁcantly delayed auditory brainstem responses (ABRs)
were measured in a group of normally hearing workers pro-
fessionally exposed to toluene.
13
Xylene is a solvent structurally related to toluene.
14
There is no literature on the effect of xylene, acting as a
single agent, on the auditory pathway in humans.
We present a case of an adult patient with hearing loss
and auditory complaints attributed to auditory nerve
pathology, i.e. auditory neuropathy or dys-synchrony.
This patient’s hearing complaints developed at the time
of xylene exposure, in the absence of any other risk
factors for auditory neuropathy or dys-synchrony (as per
his medical history).
Case report
A 60-year-old man presented to the otoneurology depart-
ment with a 40-year history of hearing difﬁculties. His
symptoms had begun in his 20s while researching for his
PhD and after exposure to the solvent xylene. He had
worked in a small basement hut where xylene leaked into
a water tank and escaped into the atmosphere. It was esti-
mated that this exposure had occurred over a six-month
period; the basement hut had been small with little or no
ventilation.
A few months after the xylene exposure, the patient had
noticed problems hearing in the presence of background
noise. His symptoms had gradually deteriorated over
time. However, he had been discharged from audiology
departments on two occasions due to normal pure tone
audiometry results. He had been diagnosed with auditory
neuropathy or dys-synchrony at the age of 50 years, at
which time he had tried both analogue and digital
hearing aids but found them of no beneﬁt.
On presentation to our clinic in March 2006, the patient
described an inability to hear speech in the presence of
noise and to understand people with accents, and the
need to lip-read and concentrate when anyone spoke
to him. He had given up using the telephone and avoided
noisy social situations. The patient had no family history
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462of early onset hearing impairment. He could not recall any
other signiﬁcant event or illness before his hearing pro-
blems began.
The patient’s medical history included a right-sided
sphenoid wing meningioma removal in October 2005.
Due to the tumour’s location, it was deemed highly unli-
kely that this had caused the patient’s audiological symp-
toms. No neurological impairments were identiﬁed and
the patient had normal nerve conduction. No central
nervous system deﬁcits or sense impairment (often associ-
ated with solvent exposure) were identiﬁed. Previous mag-
netic resonance imaging and computed tomography (CT)
scans, performed following surgery, did not show any
residual tumour and were otherwise normal.
Pure tone audiometry and acoustic reﬂex threshold
results are illustrated in Figure 1. In this patient, the com-
bination of absent or raised (.110 dBHL) ipsi- or contral-
ateral acoustic reﬂex threshold and absent ABR in the
presence of otoacoustic emissions was consistent with the
diagnosis of bilateral auditory neuropathy or dys-
synchrony.15,16 Maximum speech recognition scores of 66
and 63 per cent at 60 dBHL were present on the right
and left respectively, with a signiﬁcant rollover of 55 and
5 per cent at higher intensities; this was worse than would
be predicted from the audiogram.
17 Poor temporal proces-
sing was demonstrated by this patient’s inability to com-
plete gaps in noise testing,
18 which had to be abandoned
due to the patient’s random answers (Table I). Central
auditory processing tests,
19 which are sensitive to lesions
of the central auditory pathway, were abnormal in at least
one ear for each test (Table I).
Discussion
This case report presents a sequence of events and facts
that may be linked, and the authors are aware that there
is no hard evidence of pathology caused by xylene
exposure. Our subject was exposed to xylene over a rela-
tively small time scale (six months), and there is no quanti-
tative information regarding the concentration of xylene in
the atmosphere at the time (although the laboratory was
small and inadequately ventilated). However, Dick
reported that there is no real deﬁnition of what is regarded
as a signiﬁcant exposure to solvents, and no verdict on
whether the important determinant of adverse effects is
the lifetime (cumulative) exposure or the peaks (intensity)
of exposure.1 In addition, the subject could have idiopathic
auditory neuropathy or dys-synchrony, although the
majority of reported cases (80 per cent) present in conjunc-
tion with speciﬁc medical risk factors and generalised neu-
ropathic disorders.
20 Despite these factors, reporting this
case may be of some importance, given the clinical
setting, regarding the possible speciﬁc toxicity of xylene
on the auditory nerve and/or central auditory system in
humans.
Auditory neuropathy or dys-synchrony is deﬁned as
reduced and/or asynchronous auditory nerve function, in
the presence of normal outer hair cell function.
15 The
FIG.1
Pure tone audiogram and acoustic reﬂexes (ARTs) obtained in March 2006.
CLINICAL RECORD 463possible sites of lesion in this condition include the
cochlear inner hair cells, the synapse between the inner
hair cells and the type I auditory nerve ﬁbres, and the audi-
tory nerve itself.
20 The mechanism of auditory dysfunction
may vary between individuals, and is thought to relate to
either a dys-synchrony of the auditory nerve (e.g. due to
myelin damage) or a reduction in the numbers of neural
elements contributing to the volume-conducted response
(e.g. due to axon-related neuropathies and inner hair
cells lesions).
An inability to follow temporal ﬂuctuations is likely to
be the underlying cause for the poor speech recognition
experienced by patients with auditory neuropathy or dys-
synchrony;
21 this was demonstrated by the inability of our
patient to complete gaps in noise testing. The abnormalities
detected in the central auditory processing tests may be
attributed to disordered auditory nerve input and/or
central auditory involvement. However, in view of the
potential toxicity of solvents recorded previously at this
higher level, central involvement at the level of the auditory
cortex cannot be ruled out. Therefore, we may have a mixed
picture: intact cochlea, impaired auditory nerve, but also
possible impairment at the level of the brainstem and above.
In humans, many studies have investigated the effect of
mixed solvents (including xylene) on the auditory system,
but none have investigated the effect of xylene acting as a
single agent. Xylene is structurally related to toluene,
14
and some human studies have examined the auditory path-
ways affected by this latter solvent more closely. Morata
et al. carried out various audiological tests on workers
from a printing factory who had been exposed to toluene
or mixed solvents.
5 The results demonstrated aninteraction
between toluene and noise exposure which resulted in a
greater risk of hearing impairment. Interestingly, the
observed hearing losses were only mild (,40 dBHL) and
reﬂexes were present in most cases. However, the noise
plus toluene group had a greater percentage of cases with
reﬂex decay, particularly for contralateral stimulation,
compared with ipsilateral stimulation. Morata and col-
leagues suggested that, in these workers, the observed
hearing loss showed an additional central component at
the intra-axial brainstem level.
Metrick and Brenner reported the cases of two young
adults with neurological disorders secondary to spray
paint (toluene) abuse. These patients had high frequency
hearing losses and normal reﬂexes.
6 Their ABRs showed
the presence of waves I and II but the absence of later
waves, suggesting bilateral lower brainstem dysfunction.
6
Both patients had abnormal CT scans showing evidence
of brainstem atrophy.
. Audiological studies of humans exposed to solvents
have demonstrated peripheral hearing losses and/or
impairment of the central auditory pathway (i.e.
brainstem and above)
. Solvents should be considered as individual
substances with speciﬁc toxicities; however, it is
difﬁcult to test for this in humans
. This is the ﬁrst report on the possible effects of
xylene acting as a single agent on the auditory
pathway in a human with retrocochlear hearing loss
A study by Abbate et al. reported results that perhaps
compare most closely to our case. These authors found a
signiﬁcant delay in ABR latencies, and a signiﬁcant delay
in interpeak latencies (compared with a control group)
for waves I, III and V at click rates of 11.1 and 90 clicks
per second, for workers professionally exposed to
toluene.
13 Both groups were controlled for noise exposure
and neurological diseases, and all workers had thresholds
below 20 dB. Interestingly, waves I–III were more signiﬁ-
cantly altered than wave V. Central auditory tests were
not carried out. Abbate and colleagues proposed that the
wave I alterations found could be attributed to the solvent’s
effect on the peripheral receptor structures of the auditory
nerve, because of its liposolubility. This could impair the
membrane integrity of the peripheral receptor and/or
modify the structure of the junctional site, resulting in
alteration of the stimulus transduction mechanism.
Xylene is more liposoluble than toluene;
14 due to its
TABLE I
CENTRAL AUDITORY PROCESSING TESTS AND RESULTS
Test Description Pt response Score
FPT Presentation of 3-tone sequence
(varied combination of low
frequency (880 Hz) & high
frequency (1122 Hz) stimuli)
Description of each sequence
(e.g. high, low, high)
80% right
53% left
30 trials per ear
Pass rate 80% correct
DPT Presentation of 3-tone sequence
(varied combination of a long
duration (500 ms) and a short
duration (250 ms))
Description of each sequence
(e.g. long, long, short)
63% right
73% left
Interstimulus interval ¼ 330 ms
30 trials per ear
Pass rate 70% correct
GIN 6-s burst of white noise containing 0–3
gaps varying in duration (2–20 ms)
& timing within the noise
Identiﬁcation of number of gaps heard
within noise
Abandoned as patient gave random
answers
36 trials each ear
Pass rate: shortest gap detection 6m s
in at least 50% of trials (i.e. at least
3/6 trials)
Pt ¼ patient; FPT ¼ frequency pattern test;
19 DPT ¼ duration pattern test;
19 GIN ¼ gaps in noise test.
18 See text and references for
further details.
T H J DRAPER, D-E BAMIOU 464structural similarity, it could be proposed that xylene has a
similar mechanism of toxicity on the human auditory
nerve.
This is the ﬁrst report of retrocochlear hearing loss in a
human adult patient following xylene exposure and in the
absence of any other risk factor. Caution should be noted
regarding the length of time the subject was exposed to
the solvent, and the fact that no inferences can be made
about the concentration or biochemical properties of the
solvent. However, the test results may provide some
insight into the effect of xylene as an isolated agent on
the human auditory pathway.
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